Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma

American Journal of Clinical Pathology

Volumn 110, Issue 6, 1998, Pages 719-722

  Cochran, Alistair J ^e   Bailly, Christiane ^g   Cook, Martin ^g   Crotty, Kerry ^a   McCarthy, Stan ^a   Mihm, Martin ^b   Mooi, Walter ^c   Sagebiel, Richard ^d   LiVolsi, Virginia ^f  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g NONE

Author keywords

Malignant melanoma; Skin

Indexed keywords

ARTICLE; CANCER INVASION; EXCISION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MELANOMA; MITOSIS RATE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; TUMOR GROWTH;

EID: 0031769426     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.6.719     Document Type: Article

References (11)

1. McGovern VJ, Mihm MC, Bailly C, et al. The classification of malignant melanoma and its histologic reporting. Cancer (Philad). 1973;32:1446-1457.
2. McGovern VJ, Cochran AJ, van der Esch, et al. The classification of malignant melanoma: its histological reporting and registration. A revision of the 1972 Sydney classification. Pathology. 1986;18:12-21.
3. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-908.
4. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biological behavior. In: Montagna W, Hu F, eds. Advances in Biology of the Skin. Vol 8. London, England: Pergamon Press; 1967:621-627.
5. Clark WH Jr, Elder DE, Guerry D IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893-1904.
6. Kopf AW, Welkovich B, Frankel RE, et al. Thickness of malignant melanoma: global analysis of related factors. J Dematol Surg Oncol. 1987;13:345-390, 401-420.
7. Vollmer RT. Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu. 1989;24:383-407.
8. Schuchter L, Schultz DJ, Synnestvedt M, et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med. 1996;125(5):369-375.
9. Ruiter DJ, Brocker E-B. Immunohistochemistry in the evaluation of melanocytic tumors. Semin Diagn Pathol. 1993;10:76-91.
10. Bhuta SB, Mirra J, Cochran AJ. Myxoid malignant melanoma. Am J Surg Pathol. 1986;10:203-211.
11. Cochran AJ, Robert ME, Wen D-R. Pathology of the lymph nodes in patients with malignant melanoma. State Art Rev Pathol. 1994;2:385-400.